[8-K] Axiom Intelligence Acquisition Corp 1 Units Reports Material Event

Rhea-AI Filing Summary

Axiom Intelligence Acquisition Corp 1 has completed its initial public offering (IPO), raising $200 million through the sale of 20 million units at $10.00 per unit, including 2.5 million units from partial exercise of the overallotment option. Each unit comprises one Class A ordinary share and one right to receive one-tenth of a Class A ordinary share upon business combination.

Key developments include:

• Simultaneous private placement of 600,000 units raising additional $6 million
• $200 million placed in trust account (including $8 million deferred underwriting fees)
• Appointment of three new directors: Dr. Claire Handby, Steven Leighton, and Christopher Ellis to board and committees
• Company has 24 months to complete initial business combination
• Filed amended and restated memorandum and articles of association

The SPAC trades on Nasdaq under symbols AXINU (units), AXIN (shares), and AXINR (rights). The company qualifies as an emerging growth company.

Positive

• Successfully completed IPO raising $200M through sale of 20M units at $10/unit, including 2.5M units from over-allotment exercise
• Secured additional $6M through private placement of 600,000 units at $10/unit with Sponsor and underwriters
• Strengthened corporate governance with appointment of three new independent directors to board committees
• $200M placed in trust account for potential business combination, providing significant acquisition capital

Negative

• Company has limited 24-month window to complete business combination or must return funds to investors
• $8M in deferred underwriting commissions reduces available capital for acquisition
• As a blank check company, no current business operations or revenue generation

Insights

SPAC Analyst

Axiom Intelligence Acquisition Corp 1 completed its $200M IPO, becoming a new Cayman Islands-based SPAC with a 24-month acquisition timeline.

This 8-K discloses that Axiom Intelligence Acquisition Corp 1 has successfully completed its initial public offering (IPO), raising $200 million through the sale of 20 million units at $10 per unit. The units consist of one Class A ordinary share and one right to receive one-tenth of a share upon completion of a business combination.

The entire IPO proceeds plus $6 million from private placement units ($200M total) have been placed in trust, available only upon business combination completion, shareholder-approved charter amendments, or liquidation. The SPAC has 24 months to complete an acquisition or return funds to investors.

As typical for SPACs, the company has entered into standard agreements including underwriting, trust, registration rights, and indemnification agreements. The sponsor, Axiom Intelligence Holdings 1 LLC, purchased private placement units, and the company appointed three independent directors (Dr. Claire Handby, Steven Leighton, and Christopher Ellis).

The filing indicates the SPAC is structured as a Cayman Islands entity, which often provides tax advantages and flexibility for international transactions. With $2 million in working capital and a typical two-year timeline, Axiom Intelligence now begins its search for a suitable acquisition target.

false --12-31 0002057030 0002057030 2025-06-17 2025-06-17 0002057030 AXINU:UnitsEachConsistingOfOneClassOrdinaryShareAndOneRightMember 2025-06-17 2025-06-17 0002057030 AXINU:ClassOrdinarySharesParValue0.0001PerShareMember 2025-06-17 2025-06-17 0002057030 AXINU:RightsEachRightEntitlingHolderToReceiveOnetenth110OfOneClassOrdinaryShareMember 2025-06-17 2025-06-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): June 17, 2025

Axiom Intelligence Acquisition Corp 1

(Exact name of registrant as specified in its charter)

Cayman Islands		001-42708		98-1849669
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

Berkeley Square House, 2nd Floor
Berkeley Square

London W1J 6BD

United Kingdom

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: +44 20 3973 7928

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Units, each consisting of one Class A ordinary share and one right		AXINU		The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per share		AXIN		The Nasdaq Stock Market LLC
Rights, each right entitling the holder to receive one-tenth (1/10) of one Class A ordinary share		AXINR		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01. Entry into a Material Definitive Agreement.

On June 20, 2025, Axiom Intelligence Acquisition Corp 1 (the “Company”) consummated its initial public offering (“IPO”) of 20,000,000 units (the “Units”), including 2,500,000 units sold pursuant to the partial exercise of the underwriters’ over-allotment option. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $200,000,000. Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A Ordinary Shares”), and one right to receive one-tenth (1/10) of one Class A Ordinary Share upon the consummation of the Company’s initial business combination (each, a “Share Right”).

In connection with the IPO, the Company entered into the following agreements, forms of which were previously filed as exhibits to the Company’s registration statement on Form S-1 (File No. 333-287279) for the IPO, initially filed with the U.S. Securities and Exchange Commission (the “Commission”) on May 14, 2025 (as amended, the “Registration Statement”):

● An Underwriting Agreement, dated June 17, 2025, by and among the Company, Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC (“CCM”), and Seaport Global Securities LLC (“Seaport”), as representatives of the several underwriters, a copy of which is attached as Exhibit 1.1 hereto and incorporated herein by reference.

● A Share Rights Agreement, dated June 17, 2025, by and between the Company and Continental Stock Transfer & Trust Company, as rights agent, a copy of which is attached as Exhibit 4.1 hereto and incorporated herein by reference.

● An Investment Management Trust Agreement, dated June 17, 2025, by and between the Company and Continental Stock Transfer & Trust Company, as trustee, a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference.

● A Registration Rights Agreement, dated June 17, 2025, by and among the Company, Axiom Intelligence Holdings 1 LLC (the “Sponsor”), CCM and Seaport, as representatives of the several underwriters, a copy of which is attached as Exhibit 10.2 hereto and incorporated herein by reference.

● A Private Placement Units Purchase Agreement, dated June 17, 2025 (the “Sponsor Private Placement Units Purchase Agreement”), by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.3 hereto and incorporated herein by reference.

● A Private Placement Units Purchase Agreement, dated June 17, 2025 (the “Representatives’ Private Placement Units Purchase Agreement”), by and among the Company, CCM and Seaport, a copy of which is attached as Exhibit 10.4 hereto and incorporated herein by reference.

● A Letter Agreement, dated June 17, 2025, by and among the Company, its officers, its directors and the Sponsor, a copy of which is attached as Exhibit 10.5 hereto and incorporated herein by reference.

● An Administrative Services Agreement, dated June 17, 2025, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.6 hereto and incorporated herein by reference.

● Indemnity Agreements, dated June 17, 2025, by and among the Company and each director and officer of the Company, a form of which is attached as Exhibit 10.7 hereto and incorporated herein by reference.

1

Item 3.02. Unregistered Sales of Equity Securities.

Simultaneously with the closing of the IPO, pursuant to the Sponsor Private Placement Units Purchase Agreement and the Representatives’ Private Placement Units Purchase Agreement, the Company completed the private sale of an aggregate of 600,000 units (the “Private Placement Units”) to the Sponsor, CCM and Seaport at a price of $10.00 per Private Placement Unit for an aggregate purchase price of $6,000,000. The Private Placement Units (and underlying securities) are identical to the Units sold in the IPO, except as otherwise disclosed in the Registration Statement. No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Units was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 17, 2025, in connection with the IPO, Dr. Claire Handby, Steven Leighton and Christopher Ellis (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”). Effective June 17, 2025, each of Dr. Handby, Mr. Leighton and Mr. Ellis was appointed to the Board’s Audit Committee, with Mr. Ellis serving as chair of the Audit Committee. Each of Dr. Handby, Mr. Leighton and Mr. Ellis was also appointed to the Board’s Compensation Committee, with Dr. Handby serving as chair of the Compensation Committee.

On June 17, 2025, the Company entered into indemnity agreements with each of the Directors and executive officers, which require the Company to indemnify each of them to the fullest extent permitted by applicable law and to advance expenses incurred as a result of any proceeding against them as to which they could be indemnified. The foregoing summary of the indemnity agreements does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the form of indemnity agreement, which is filed as Exhibit 10.7 to this Current Report on Form 8-K and incorporated herein by reference.

Item 5.03. Amendments to the Amended and Restated Memorandum and Articles of Association; Change in Fiscal Year.

In connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”) with the Cayman Islands Registrar of Companies, which was effective on June 18, 2025. The terms of the Amended and Restated Memorandum and Articles of Association are set forth in the Registration Statement and are incorporated herein by reference. A copy of the Amended and Restated Memorandum and Articles of Association is attached as Exhibit 3.1 hereto and incorporated herein by reference.

Item 8.01. Other Events.

A total of $200,000,000 of the proceeds from the IPO and the sale of the Private Placement Units (which amount includes $8,000,000 of the underwriters’ deferred underwriting commissions) was placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company, acting as trustee, with the remaining $2,000,000 of proceeds from the Private Placement Units going to the Company’s working capital account (a portion of which will be used to pay offering expenses). Except with respect to interest earned on the funds in the trust account that may be released to the Company to pay its taxes and up to $100,000 for dissolution expenses, the funds held in the trust account will not be released from the trust account until the earliest of (i) the completion of the Company’s initial business combination, (ii) the redemption of the Company’s public shares if it is unable to complete its initial business combination within 24 months from the closing of the IPO (or by such earlier liquidation date as the Company’s board of directors may approve), subject to applicable law, and (iii) the redemption of the Company’s public shares properly submitted in connection with a shareholder vote to amend the Company’s Amended and Restated Memorandum and Articles of Association to modify the substance or timing of its obligation to redeem 100% of the Company’s public shares if it has not consummated an initial business combination within 24 months from the closing of the IPO or with respect to any other material provisions relating to shareholders’ rights or pre-initial business combination activity.

2

On June 17, 2025, the Company issued a press release announcing the pricing of the IPO, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K.

On June 20, 2025, the Company issued a press release announcing the closing of the IPO, a copy of which is attached as Exhibit 99.2 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

The following exhibits are being filed herewith:

Exhibit No.		Description
1.1		Underwriting Agreement, dated June 17, 2025, among the Company, CCM and Seaport, as representatives of the several underwriters.
3.1		Amended and Restated Memorandum and Articles of Association of the Company.
4.1		Share Rights Agreement, dated June 17, 2025, by and between the Company and Continental Stock Transfer & Trust Company.
10.1		Investment Management Trust Agreement, dated June 17, 2025, by and between the Company and Continental Stock Transfer & Trust Company.
10.2		Registration Rights Agreement, dated June 17, 2025, by and among the Company, the Sponsor, CCM and Seaport, as representatives of the several underwriters.
10.3		Private Placement Units Purchase Agreement, dated June 17, 2025, between the Company and the Sponsor.
10.4		Private Placement Units Purchase Agreement, dated June 17, 2025, between the Company, CCM and Seaport.
10.5		Letter Agreement, dated June 17, 2025, by and among the Company, the Sponsor and each of the officers and directors of the Company.
10.6		Administrative Services Agreement, dated June 17, 2025, between the Company and the Sponsor.
10.7		Form of Indemnity Agreement.
99.1		Press Release, dated June 17, 2025.
99.2		Press Release, dated June 20, 2025.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

3

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	AXIOM INTELLIGENCE ACQUISITION CORP 1
	By:	/s/ Douglas Ward
		Name:	Douglas Ward
		Title:	Chief Executive Officer
Dated: June 24, 2025

4

FAQ

How much did AXINU raise in its IPO in June 2025?

AXINU raised $200,000,000 in its IPO by selling 20,000,000 units at $10.00 per unit, including 2,500,000 units from the partial exercise of the underwriters' over-allotment option. Additionally, the company raised $6,000,000 through a private placement of 600,000 units.

What is the structure of AXINU's IPO units?

Each AXINU unit consists of one Class A ordinary share (par value $0.0001) and one right to receive one-tenth (1/10) of one Class A Ordinary Share upon the consummation of the company's initial business combination.

Who are the new directors appointed to AXINU's board in June 2025?

On June 17, 2025, AXINU appointed three new directors: Dr. Claire Handby, Steven Leighton, and Christopher Ellis. Mr. Ellis was appointed as chair of the Audit Committee, while Dr. Handby was appointed as chair of the Compensation Committee.

What is AXINU's timeline to complete a business combination?

AXINU has 24 months from the closing of its IPO (June 20, 2025) to complete its initial business combination. If unable to do so, the company must redeem 100% of its public shares, subject to applicable law.

How much of AXINU's IPO proceeds are held in trust?

$200,000,000 of the proceeds (including $8,000,000 of underwriters' deferred commissions) is held in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company. The funds can only be released upon completion of a business combination, redemption of shares, or certain other specific conditions.